Could a malaria drug boost leukemia treatment?
Disease control
Ongoing
This Phase 2 trial in Nigeria tests whether adding artesunate, a malaria drug, to the standard CML medication imatinib can improve treatment outcomes. 75 adults with chronic myeloid leukemia will receive either imatinib alone or imatinib plus artesunate. The goal is to see if the…
Phase: PHASE2 • Sponsor: Obafemi Awolowo University • Aim: Disease control
Last updated Jun 26, 2026 14:03 UTC